Bath and Exeter sit barely 80 miles apart in England's South West, share a university-city profile, and draw from broadly similar populations. Yet according to PharmSee's analysis of NHSBSA dispensing data and NHS Digital contractor records, the two cities diverge sharply on the metric that matters most to pharmacy operators: dispensing revenue per active branch.

Exeter's active pharmacies average approximately £151,513 in annual dispensing revenue. Bath's average roughly £71,766 — less than half. The gap is one of the widest between any two comparably sized English cities measured by PharmSee.

The numbers at a glance

Source: PharmSee analysis of NHSBSA dispensing data and NHS Digital pharmacy register. Zero-revenue entries may reflect data-reporting lag, temporary closures, or operational changes rather than permanent closure.

Why Exeter earns more per branch

Three factors explain most of the gap.

Higher GP density relative to pharmacies. Exeter's GP-to-pharmacy ratio of 1.42:1 is the highest PharmSee has recorded in any English city outside Liverpool. More GP practices per pharmacy typically means more prescriptions flowing to each dispensing site. Bath's 1.22:1 ratio, while still above the national average, generates less prescription volume per branch.

Fewer active pharmacies sharing the revenue. Exeter has just 18 pharmacies with recorded dispensing activity, compared to Bath's 22. When five of Exeter's eight zero-revenue entries are former Lloyds branches — reflecting the chain's 2023 exit from the English market — the effect is a smaller pool of operating pharmacies splitting a larger revenue base.

Area deprivation and prescribing patterns. Parts of Exeter's catchment, particularly the Wonford and St Thomas areas, sit in more deprived IMD deciles than central Bath. Higher deprivation tends to correlate with higher prescribing volumes, a relationship documented across multiple English cities in PharmSee's dispensing revenue ranking.

The Lloyds legacy

Exeter carries five former Lloyds branches on its NHSBSA register, all showing zero dispensing revenue. Bath has one. This difference alone shifts the active-pharmacy count significantly in a market of only 26-27 total branches. It is worth noting that NHSBSA register entries can persist for several quarters after a branch ceases trading; the zero-revenue figure should be read as an upper bound on inactive sites rather than a precise closure count.

Vacancy picture

Within a 25-mile radius, PharmSee tracks 48 pharmacy vacancies near Bath and 19 near Exeter across 11 public job sources. Bath's higher vacancy count partly reflects its proximity to Bristol, which pulls in regional postings.

In Exeter, NHS trust roles account for nearly half of all listings (9 of 19), suggesting the Royal Devon University Healthcare NHS Foundation Trust is a significant local employer. Bath's vacancy mix skews more towards community pharmacy chains, with one national chain accounting for 21 of 48 postings.

For current vacancies in both cities, see PharmSee's job search tool.

What this means for pharmacy operators

For independent operators considering the South West, the data suggests Exeter offers a higher revenue ceiling per branch but fewer immediate job openings. Bath presents more competition from chain employers and lower per-branch revenue, but a tighter GP-to-pharmacy ratio than many English cities and a strong independent sector (74% of branches).

Both cities sit above the English average for GP-to-pharmacy ratios, meaning neither qualifies as a "pharmacy desert" — but Exeter's 1.42:1 figure places it among the most underserved cities PharmSee has measured, at least by this metric.

Explore both markets in detail using PharmSee's pharmacy search and location analysis tools.

Methodology

All figures are drawn from PharmSee's database of NHSBSA dispensing contractor records and NHS Digital pharmacy register data. Revenue figures represent NHS dispensing revenue only and do not include retail sales, private prescriptions, or enhanced service payments. The 3-mile radius is PharmSee's standard urban comparison metric. Zero-revenue entries may reflect data-reporting lag rather than permanent closure. Data snapshot: April 2026.